| Literature DB >> 11012065 |
Abstract
In this paper the authors describe the first use of a new liquid embolic agent (Onyx) to treat spinal cord arteriovenous malformations (AVMs). Because its properties make it more predictable to use than currently available liquid agents, the authors believe that this material has great potential in the endovascular management of both spinal cord and brain AVMs. This very promising agent merits further clinical study.Entities:
Mesh:
Substances:
Year: 2000 PMID: 11012065 DOI: 10.3171/spi.2000.93.2.0304
Source DB: PubMed Journal: J Neurosurg ISSN: 0022-3085 Impact factor: 5.115